Essig M, Debus J, Schlemmer H P, Hawighorst H, Wannenmacher M, van Kaick G
Forschungsschwerpunkt Radiologische Diagnostik und Therapie, Deutsches Krebsforschungszentrum, Heidelberg.
Strahlenther Onkol. 2000 Feb;176(2):84-94. doi: 10.1007/pl00002333.
FLAIR MR imaging has shown to be a valuable imaging modality in pathologic lesions of the brain including intra-axial brain tumors. The aim of the study was to assess the value of a FLAIR technique in the planning process of stereotactic radiotherapy in patients with cerebral gliomas and metastases.
Thirty-five patients with cerebral gliomas and 12 patients with a total of 39 cerebral metastases were examined by T2/PD-weighted fast spin-echo, fast FLAIR prior and after contrast and contrast enhanced T1-weighted spin-echo using identical slice parameters. The images were evaluated by using quantitative and qualitative criteria. Quantitative criteria were tumor-to-background and tumor-to-cerebrospinal fluid contrast and contrast-to-noise. The qualitative evaluation was performed as a multireader analysis concerning lesion detection, lesion delineation and image artifacts.
In the qualitative evaluation (Table 3 and 6), all readers found the fast FLAIR images to be superior to fast spin-echo in the exact delineation of cerebral tumors (p < 0.001) and the delineation of enhancing and non enhancing tumor parts. Fast FLAIR was superior in the delineation of cortically located and small lesions but was limited in lesions adjacent to the ventricles. Fast FLAIR provided a significantly better tumor-to-CSF contrast and tumor-to-CSF contrast-to-noise (p < 0.001) (Tables 1, 2a, 2b, 4, 5). The tumor-to-background contrast and tumor-to-background contrast-to-noise of the fast FLAIR images were lower than that of T2-weighted spin-echo images but were significantly increased after the application of contrast media. FLAIR images had more image artifacts, but the image interpretation was not influenced.
FLAIR MR imaging was found to be a valuable sequence in the planning protocol of stereotactic radiotherapy. The concurrent presentation of enhancing and non enhancing tumor tissue on contrast enhanced fast FLAIR imaging enables to use a single imaging sequence in the treatment protocol. This enables to load a reduced image amount into the radiotherapy planning software, is therefore time saving and reduces potential errors.
液体衰减反转恢复(FLAIR)磁共振成像已被证明是一种在包括脑内肿瘤在内的脑部病理病变中具有重要价值的成像方式。本研究的目的是评估FLAIR技术在脑胶质瘤和脑转移瘤患者立体定向放射治疗计划过程中的价值。
35例脑胶质瘤患者和12例共39个脑转移瘤患者接受了T2/质子密度加权快速自旋回波、对比剂注射前后的快速FLAIR以及对比增强T1加权自旋回波检查,使用相同的层面参数。通过定量和定性标准对图像进行评估。定量标准包括肿瘤与背景、肿瘤与脑脊液的对比度以及对比噪声比。定性评估采用多观察者分析,涉及病变检测、病变勾画和图像伪影。
在定性评估中(表3和6),所有观察者均发现快速FLAIR图像在脑肿瘤的精确勾画(p < 0.001)以及增强和非增强肿瘤部分的勾画方面优于快速自旋回波。快速FLAIR在皮质定位和小病变的勾画方面更具优势,但在脑室附近的病变中存在局限性。快速FLAIR提供了显著更好的肿瘤与脑脊液对比度以及肿瘤与脑脊液对比噪声比(p < 0.001)(表1、2a、2b、4、5)。快速FLAIR图像的肿瘤与背景对比度以及肿瘤与背景对比噪声比低于T2加权自旋回波图像,但在应用对比剂后显著增加。FLAIR图像有更多的图像伪影,但不影响图像解读。
FLAIR磁共振成像被发现是立体定向放射治疗计划方案中的一个有价值的序列。对比增强快速FLAIR成像上增强和非增强肿瘤组织的同时呈现使得在治疗方案中能够使用单一成像序列。这使得能够将减少的图像数量加载到放射治疗计划软件中,因此节省时间并减少潜在误差。